New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP is investiga

New York, New York--(Newsfile Corp. - September 16, 2026) - Kaplan Fox & Kilsheimer LLP is investiga

iRadimed (NASDAQ: IRMD - Get Free Report) and Medline (NASDAQ: MDLN - Get Free Report) are both heal

Medline Inc. (NASDAQ: MDLN) shareholders should email fletcher@fmoorelaw.com NEW YORK, Sept. 15, 202

Medline Inc. (MDLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

New York, New York--(Newsfile Corp. - September 14, 2026) - Kaplan Fox & Kilsheimer LLP is investiga

HB Wealth Management LLC bought a new stake in shares of Medline (NASDAQ: MDLN) during the undefined

New York, New York--(Newsfile Corp. - September 10, 2026) - Kaplan Fox & Kilsheimer LLP is investiga

New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigat

Nykredit A S purchased a new stake in Medline (NASDAQ: MDLN) in the undefined quarter, according to

H&F Corporate Investors X Ltd. reduced its position in shares of Medline (NASDAQ: MDLN) by 18.0% in

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigat

NORTHFIELD, Ill., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today a

New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigat

New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP is investigatin

RADNOR, Pa., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a

FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to steril

JP Morgan analyst Lisa Gill maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the pric

Wells Fargo analyst Stephen Baxter maintains Medline (NASDAQ:MDLN) with a Equal-Weight and lowers

TD Cowen analyst Charles Rhyee maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price ta

RBC Capital analyst Ryan Halsted maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

Truist Securities analyst Jailendra Singh maintains Medline (NASDAQ:MDLN) with a Buy and lowers t

Evercore ISI Group analyst Elizabeth Anderson maintains Medline (NASDAQ:MDLN) with a Outperform a

Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensu

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Allina Health

Jim Cramer says Medline is "probably" the best IPO of 2026 and expects AST SpaceMobile to be

Medline (MDLN) faces near-term headwinds after a major CA warehouse fire. William Blair analysts bre

Baird analyst Eric Coldwell maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the pric

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/m

Barclays analyst Glen Santangelo maintains Medline (NASDAQ:MDLN) with a Overweight and lowers the

Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in t

Medline (NASDAQ:MDLN) today announced that it signed a new Prime Vendor agreement with Rural Medical

Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders aff

BNP Paribas analyst Navann Ty maintains Medline (NASDAQ:MDLN) with a Neutral and lowers the price

Tigress Financial analyst Ivan Feinseth maintains Medline (NASDAQ:MDLN) with a Buy and raises the

Citigroup analyst Patrick Donnelly maintains Medline (NASDAQ:MDLN) with a Buy and lowers the pric

Bernstein analyst Lee Hambright maintains Medline (NASDAQ:MDLN) with a Outperform and lowers the

https://www.fda.gov/medical-devices/letters-health-care-providers/disruptions-availability-neurosurg

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensu

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=219163

Medline (NASDAQ:MDLN) announced a strategic agreement to implement next-generation warehouse automat

U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting ear

FDA warns Medline over device quality lapses, citing CAPA failures, contamination risks, and unresol